GREAT POINT PARTNERS LLC Holdings
GREAT POINT PARTNERS LLC is an investment fund managing more than 415.31M US dollars. The largest holdings include Xenon Pharmaceuticals, Jazz Pharmaceuticals and POINT Biopharma Global. In Q3 2022 the fund bought assets of total value of 152.84M US dollars and sold assets of total value of 125.84M US dollars.
GREAT POINT PARTNERS LLC portfolio value:
$415.31M
portfolio value
GREAT POINT PARTNERS LLC quarter portfolio value change:
+22.33%
quarter
GREAT POINT PARTNERS LLC 1 year portfolio value change:
-8.98%
1 year
GREAT POINT PARTNERS LLC 3 years portfolio value change:
+76.11%
3 years
GREAT POINT PARTNERS LLC 5 years portfolio value change:
+221.70%
5 years
GREAT POINT PARTNERS LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | 39203000 | 4900000 |
| Q2 2016 | 89302000 | 41610000 |
| Q3 2016 | 121666000 | 104933000 |
| Q4 2016 | 121726000 | 33311000 |
| Q1 2017 | 132543000 | 106945000 |
| Q2 2017 | 159938000 | 99168000 |
| Q3 2017 | 81745000 | 187607000 |
| Q4 2017 | 217212000 | 63802000 |
| Q1 2018 | 228152000 | 154721000 |
| Q2 2018 | 168157000 | 208443000 |
| Q3 2018 | 174261000 | 169625000 |
| Q4 2018 | 217628000 | 125314000 |
| Q1 2019 | 188741000 | 72174000 |
| Q2 2019 | 219305000 | 252251000 |
| Q3 2019 | 267955000 | 95702000 |
| Q4 2019 | 413068000 | 321258000 |
| Q1 2020 | 141873000 | 242263000 |
| Q2 2020 | 572680000 | 228378000 |
| Q3 2020 | 142467000 | 279834000 |
| Q4 2020 | 178166000 | 675953000 |
| Q1 2021 | 149230000 | 271132000 |
| Q2 2021 | 123134000 | 156979000 |
| Q3 2021 | 141806000 | 164700000 |
| Q4 2021 | 162321000 | 97729000 |
| Q1 2022 | 127071000 | 108080000 |
| Q2 2022 | 113770000 | 132218000 |
| Q3 2022 | 152839000 | 125835000 |
GREAT POINT PARTNERS LLC 13F holdings
| Stock |
|---|
| Portfolio share: 7.39% Portfolio value: 30.68M Avg. open price: $21.77 Current price: $38.83 P/L: +78.37% Sold -23.03% shares Q3 2022 |
| Portfolio share: 6.90% Portfolio value: 28.65M Avg. open price: $155.81 Current price: $150.97 P/L: -3.11% Bought +13.16% shares Q3 2022 |
| Portfolio share: 6.63% Portfolio value: 27.52M Avg. open price: $6.34 Current price: $6.72 P/L: +6.08% Bought +47.12% shares Q3 2022 |
| Portfolio share: 5.98% Portfolio value: 24.82M Avg. open price: $8.51 Current price: $6.78 P/L: -20.39% Bought +540.01% shares Q3 2022 |
| Portfolio share: 5.73% Portfolio value: 23.80M Avg. open price: $26.11 Current price: $20.01 P/L: -23.35% Sold -0.53% shares Q3 2022 |
| Portfolio share: 5.65% Portfolio value: 23.48M Avg. open price: N/A Current price: $2.54 P/L: N/A N/A Q3 2022 |
| Portfolio share: 5.42% Portfolio value: 22.51M Avg. open price: $14.18 Current price: $5.17 P/L: -63.53% Bought +1.42% shares Q3 2022 |
| Portfolio share: 5.24% Portfolio value: 21.76M Avg. open price: $8.01 Current price: $17 P/L: +112.23% Bought +191.59% shares Q3 2022 |
| Portfolio share: 4.55% Portfolio value: 18.88M Avg. open price: $21.71 Current price: $4.45 P/L: -79.50% Sold -27.14% shares Q3 2022 |
| Portfolio share: 3.86% Portfolio value: 16.04M Avg. open price: $16.92 Current price: $15.66 P/L: -7.45% Sold -5.88% shares Q3 2022 |
| Portfolio share: 3.47% Portfolio value: 14.4M Avg. open price: $25.27 Current price: $44.33 P/L: +75.44% Sold -39.10% shares Q3 2022 |
| Portfolio share: 3.15% Portfolio value: 13.06M Avg. open price: $55.48 Current price: $38.92 P/L: -29.85% Sold -14.89% shares Q3 2022 |
| Portfolio share: 2.90% Portfolio value: 12.03M Avg. open price: $3.91 Current price: $5.6 P/L: +43.22% Sold -20.79% shares Q3 2022 |
| Portfolio share: 2.73% Portfolio value: 11.33M Avg. open price: $29.79 Current price: $25.51 P/L: -14.37% Bought +40.33% shares Q3 2022 |
| Portfolio share: 2.52% Portfolio value: 10.46M Avg. open price: N/A Current price: $121.22 P/L: N/A N/A Q3 2022 |
| Portfolio share: 2.51% Portfolio value: 10.43M Avg. open price: N/A Current price: $9.17 P/L: N/A N/A Q3 2022 |
| Portfolio share: 2.38% Portfolio value: 9.88M Avg. open price: $17.54 Current price: $12.33 P/L: -29.70% Sold -54.97% shares Q3 2022 |
| Portfolio share: 2.27% Portfolio value: 9.42M Avg. open price: $13.57 Current price: $28.09 P/L: +107.00% Sold -30.64% shares Q3 2022 |
| Portfolio share: 2.20% Portfolio value: 9.11M Avg. open price: $5.29 Current price: $0.23 P/L: -95.69% Sold -25.31% shares Q3 2022 |
| Portfolio share: 1.82% Portfolio value: 7.57M Avg. open price: N/A Current price: $16.53 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.75% Portfolio value: 7.26M Avg. open price: $16.82 Current price: $8.31 P/L: -50.59% Bought +16.46% shares Q4 2021 |
| Portfolio share: 1.62% Portfolio value: 6.73M Avg. open price: N/A Current price: $19.95 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.49% Portfolio value: 6.20M Avg. open price: N/A Current price: $72.87 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.49% Portfolio value: 6.2M Avg. open price: N/A Current price: $4.75 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.33% Portfolio value: 5.52M Avg. open price: N/A Current price: $8.34 P/L: N/A Sold -31.79% shares Q3 2022 |
| Portfolio share: 1.05% Portfolio value: 4.38M Avg. open price: N/A Current price: $5.22 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.00% Portfolio value: 4.13M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.92% Portfolio value: 3.81M Avg. open price: $5.25 Current price: $10.07 P/L: +91.81% Bought +13.89% shares Q3 2022 |
| Portfolio share: 0.89% Portfolio value: 3.68M Avg. open price: N/A Current price: $58.07 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.87% Portfolio value: 3.63M Avg. open price: N/A Current price: $3.15 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.85% Portfolio value: 3.52M Avg. open price: N/A Current price: $1.24 P/L: N/A Sold -52.90% shares Q3 2022 |
| Portfolio share: 0.67% Portfolio value: 2.79M Avg. open price: N/A Current price: $4.17 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.54% Portfolio value: 2.26M Avg. open price: $3.64 Current price: $0.99 P/L: -72.86% Sold -21.77% shares Q3 2022 |
| Portfolio share: 0.35% Portfolio value: 1.46M Avg. open price: $100.79 Current price: $14.32 P/L: -85.79% N/A Q3 2022 |
| Portfolio share: 0.35% Portfolio value: 1.44M Avg. open price: N/A Current price: $2.87 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.35% Portfolio value: 1.43M Avg. open price: $9.78 Current price: $1.24 P/L: -87.32% Sold -12.90% shares Q3 2022 |
| Portfolio share: 0.34% Portfolio value: 1.43M Avg. open price: N/A Current price: $2.97 P/L: N/A Sold -85.78% shares Q3 2022 |
| Portfolio share: 0.34% Portfolio value: 1.41M Avg. open price: N/A Current price: $21.45 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.32% Portfolio value: 1.31M Avg. open price: $7.92 Current price: $0.47 P/L: -94.06% N/A Q2 2022 |
| Portfolio share: 0.17% Portfolio value: 692K Avg. open price: N/A Current price: $17.09 P/L: N/A Sold -82.83% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $19.52 Current price: $122.96 P/L: +529.92% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $226.95 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $15.68 Current price: $38.12 P/L: +143.15% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.14 Current price: $22.77 P/L: +41.08% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.18 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $29.47 Current price: $28.65 P/L: -2.78% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $57.43 Current price: $226.4 P/L: +294.25% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $11.68 Current price: $15.73 P/L: +34.63% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $226.95 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $47.13 Current price: $124 P/L: +163.11% Sold -100.00% shares Q3 2022 |
Showing TOP 50 GREAT POINT PARTNERS's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of GREAT POINT PARTNERS LLC?
The biggest position of the GREAT POINT PARTNERS LLC is Xenon Pharmaceuticals Inc. (XENE) with 7.39% portfolio share worth of 30.69M US dollars.
Top 5 GREAT POINT PARTNERS's holdings represent 32.63% of the portfolio:
- Xenon Pharmaceuticals Inc. (XENE) – 7.39%
- Jazz Pharmaceuticals plc (JAZZ) – 6.9%
- POINT Biopharma Global Inc. (PNT) – 6.63%
- Alpine Immune Sciences, Inc. (ALPN) – 5.98%
- Travere Therapeutics, Inc. (TVTX) – 5.73%
Who is the portfolio manager of GREAT POINT PARTNERS LLC?
The portfolio manager of the GREAT POINT PARTNERS LLC is .
What is the total asset value of the GREAT POINT PARTNERS LLC portfolio?
GREAT POINT PARTNERS LLC total asset value (portfolio value) is 415.31M US dollars.
Who is ?
is the portfolio manager of the GREAT POINT PARTNERS LLC.
What is (GREAT POINT PARTNERS LLC) fund performance?
GREAT POINT PARTNERS's quarterly performance is +22.33%, annualy -8.98%. In the past 3 years, the value of 's portfolio has increased by +76%. In the past 5 years, the value of the portfolio has increased by +222%.
What is the GREAT POINT PARTNERS LLC CIK?
GREAT POINT PARTNERS's Central Index Key is 0001281446 .